Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.

Mahlknecht P, Stockner H, Marini K, Gasperi A, Djamshidian A, Willeit P, Kiechl S, Willeit J, Rungger G, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2019 Dec 11;70:51-54. doi: 10.1016/j.parkreldis.2019.12.008. [Epub ahead of print]

PMID:
31864071
2.

Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours.

Barbosa P, Hapuarachchi B, Djamshidian A, Strand K, Lees AJ, de Silva R, Holton JL, Warner TT.

Brain. 2019 Nov 1;142(11):3580-3591. doi: 10.1093/brain/awz298.

PMID:
31603207
3.

Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

Carbone F, Djamshidian A, Seppi K, Poewe W.

CNS Drugs. 2019 Sep;33(9):905-918. doi: 10.1007/s40263-019-00661-z. Review.

4.

Saccadic Direction Errors are Associated with Impulsive Compulsive Behaviours in Parkinson's Disease Patients.

Barbosa P, Kaski D, Castro P, Lees AJ, Warner TT, Djamshidian A.

J Parkinsons Dis. 2019;9(3):625-630. doi: 10.3233/JPD-181460.

PMID:
31282422
5.

Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study).

Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K.

J Neural Transm (Vienna). 2019 Aug;126(8):1061-1072. doi: 10.1007/s00702-019-02021-z. Epub 2019 May 25.

6.

The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.

Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, Korlipara P, Morris HR, Bhatia KP, Limousin P, Foltynie T, Lees AJ, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1288-1289. doi: 10.1136/jnnp-2018-319891. Epub 2019 Feb 1. No abstract available.

PMID:
30709896
7.

The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study.

Barbosa P, Djamshidian A, Lees AJ, Warner TT.

Mov Disord Clin Pract. 2018 Oct 4;5(5):519-522. doi: 10.1002/mdc3.12671. eCollection 2018 Sep-Oct.

8.

Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate.

Magdalinou NK, Golden HL, Nicholas JM, Witoonpanich P, Mummery CJ, Morris HR, Djamshidian A, Warner TT, Warrington EK, Lees AJ, Warren JD.

Neurocase. 2018 Aug;24(4):204-212. doi: 10.1080/13554794.2018.1527368. Epub 2018 Oct 6.

9.

Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.

Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Stockner H, de Marzi R, Heim B, Djamshidian A, Willeit P, Willeit J, Kiechl S, Valent D, Krismer F, Wenning GK, Nocker M, Mair K, Poewe W, Seppi K.

Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.

PMID:
30199864
10.

Cannabinoids for Treatment of Dystonia in Huntington's Disease.

Saft C, von Hein SM, Lücke T, Thiels C, Peball M, Djamshidian A, Heim B, Seppi K.

J Huntingtons Dis. 2018;7(2):167-173. doi: 10.3233/JHD-170283.

PMID:
29562549
11.

Reflection impulsivity perceptual decision-making in patients with restless legs syndrome.

Heim B, Pertl MT, Stefani A, Heidbreder A, Zamarian L, Brandauer E, Averbeck B, Delazer M, Seppi K, Högl B, Poewe W, Djamshidian A.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):315-322. doi: 10.1002/acn3.535. eCollection 2018 Mar.

12.

The reorganization of functional architecture in the early-stages of Parkinson's disease.

Tuovinen N, Seppi K, de Pasquale F, Müller C, Nocker M, Schocke M, Gizewski ER, Kremser C, Wenning GK, Poewe W, Djamshidian A, Scherfler C, Seki M.

Parkinsonism Relat Disord. 2018 May;50:61-68. doi: 10.1016/j.parkreldis.2018.02.013. Epub 2018 Feb 8.

PMID:
29449186
13.

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.

PMID:
29436728
14.

Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.

Renaud M, Moreira MC, Ben Monga B, Rodriguez D, Debs R, Charles P, Chaouch M, Ferrat F, Laurencin C, Vercueil L, Mallaret M, M'Zahem A, Pacha LA, Tazir M, Tilikete C, Ollagnon E, Ochsner F, Kuntzer T, Jung HH, Beis JM, Netter JC, Djamshidian A, Bower M, Bottani A, Walsh R, Murphy S, Reiley T, Bieth É, Roelens F, Poll-The BT, Lourenço CM, Jardim LB, Straussberg R, Landrieu P, Roze E, Thobois S, Pouget J, Guissart C, Goizet C, Dürr A, Tranchant C, Koenig M, Anheim M.

JAMA Neurol. 2018 Apr 1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373.

15.

Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.

Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1121-1123. doi: 10.1136/jnnp-2017-317298. Epub 2017 Nov 24. No abstract available.

PMID:
29175897
16.

MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.

Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Jan;46:47-55. doi: 10.1016/j.parkreldis.2017.10.020. Epub 2017 Oct 31.

17.

Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation.

Heim B, Pertl MT, Stefani A, Delazer M, Heidbreder A, Zamarian L, Brandauer E, Seppi K, Högl B, Poewe W, Djamshidian A.

PLoS One. 2017 Apr 5;12(4):e0174793. doi: 10.1371/journal.pone.0174793. eCollection 2017.

18.

Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.

Maloney EM, Djamshidian A, O'Sullivan SS.

J Neurol Sci. 2017 Mar 15;374:47-52. doi: 10.1016/j.jns.2016.12.058. Epub 2016 Dec 28. Review.

PMID:
28108021
19.

Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's.

Djamshidian A, Poewe W.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S9-S12. doi: 10.1016/j.parkreldis.2016.12.004. Epub 2016 Dec 22. Review.

PMID:
28012951
20.

Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?

Nirenberg MJ, Djamshidian A, Heim B, Högl B, Seppi K, Poewe W.

Neurology. 2016 Dec 13;87(24):2603. No abstract available.

PMID:
27956569
21.

Reply to letter: Nonmotor symptoms in subjects without evidence of dopaminergic deficits.

Sprenger FS, Seppi K, Djamshidian A, Poewe W.

Mov Disord. 2016 Oct;31(10):1588-1589. doi: 10.1002/mds.26757. No abstract available.

PMID:
27548883
22.

A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson's Disease Patients Treated with Continuous Waking Day Apomorphine Pumps.

Barbosa P, Lees AJ, Magee C, Djamshidian A, Warner TT.

Mov Disord Clin Pract. 2016 Aug 11;4(3):323-328. doi: 10.1002/mdc3.12416. eCollection 2017 May-Jun.

23.

Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?

Heim B, Djamshidian A, Heidbreder A, Stefani A, Zamarian L, Pertl MT, Brandauer E, Delazer M, Seppi K, Poewe W, Högl B.

Neurology. 2016 Jul 5;87(1):36-40. doi: 10.1212/WNL.0000000000002803. Epub 2016 Jun 3.

PMID:
27261093
24.

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.

Mahlknecht P, Pechlaner R, Boesveldt S, Volc D, Pinter B, Reiter E, Müller C, Krismer F, Berendse HW, van Hilten JJ, Wuschitz A, Schimetta W, Högl B, Djamshidian A, Nocker M, Göbel G, Gasperi A, Kiechl S, Willeit J, Poewe W, Seppi K.

Mov Disord. 2016 Sep;31(9):1408-13. doi: 10.1002/mds.26637. Epub 2016 May 9. Review.

25.

Jumping to conclusions in untreated patients with Parkinson's disease.

de Rezende Costa FH, Averbeck B, O'Sullivan SS, Vincent MB, Rosso AL, Lees AJ, Djamshidian A.

Neuropsychologia. 2016 May;85:19-23. doi: 10.1016/j.neuropsychologia.2016.03.002. Epub 2016 Mar 5.

26.

Reply to "Nonmotor symptoms in subjects without evidence of dopaminergic deficit" authors: "Swallow DMA, Grosset KA, Grosset DG".

Sprenger FS, Seppi K, Djamshidian A, Poewe W.

Mov Disord. 2016 Mar;31(3):430-1. doi: 10.1002/mds.26543. Epub 2016 Feb 17. No abstract available.

PMID:
26888688
27.

Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes.

Reiter E, Heim B, Scherfler C, Mueller C, Nocker M, Ndayisaba JP, Loescher W, Seppi K, Lees AJ, Warner T, Poewe W, Wenning GK, Djamshidian A.

Mov Disord Clin Pract. 2016 Jan 18;3(4):382-388. doi: 10.1002/mdc3.12301. eCollection 2016 Jul-Aug.

28.

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease.

Djamshidian A, Poewe W, Högl B.

Parkinsons Dis. 2015;2015:970862. doi: 10.1155/2015/970862. Epub 2015 Nov 18. Review.

29.

Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?

Djamshidian A, Bernschneider-Reif S, Poewe W, Lees AJ.

Mov Disord Clin Pract. 2015 Oct 6;3(1):19-26. doi: 10.1002/mdc3.12242. eCollection 2016 Jan-Feb. Review.

30.

Reply: Nonmotor symptoms in subjects without evidence of dopaminergic deficits.

Sprenger FS, Seppi K, Djamshidian A, Reiter E, Nocker M, Mair K, Göbel G, Poewe W.

Mov Disord. 2015 Sep;30(10):1437-8. doi: 10.1002/mds.26336. Epub 2015 Jul 30. No abstract available.

PMID:
26227294
31.

Probable RBD and association with neurodegenerative disease markers: A population-based study.

Mahlknecht P, Seppi K, Frauscher B, Kiechl S, Willeit J, Stockner H, Djamshidian A, Nocker M, Rastner V, Defrancesco M, Rungger G, Gasperi A, Poewe W, Högl B.

Mov Disord. 2015 Sep;30(10):1417-21. doi: 10.1002/mds.26350. Epub 2015 Jul 24.

PMID:
26208108
32.

Neurobehavioral Sequelae of Psychostimulant Abuse.

Djamshidian A.

Int Rev Neurobiol. 2015;120:161-77. doi: 10.1016/bs.irn.2015.01.002. Epub 2015 Mar 6. Review.

PMID:
26070757
33.

Nonmotor symptoms in subjects without evidence of dopaminergic deficits.

Sprenger FS, Seppi K, Djamshidian A, Reiter E, Nocker M, Mair K, Göbel G, Poewe W.

Mov Disord. 2015 Jun;30(7):976-81. doi: 10.1002/mds.26204. Epub 2015 Mar 15.

PMID:
25772612
34.

Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.

De Pablo-Fernandez E, Doherty KM, Holton JL, Revesz T, Djamshidian A, Limousin P, Bhatia KP, Warner TT, Lees AJ, Ling H.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):934-6. doi: 10.1136/jnnp-2014-309460. Epub 2014 Dec 4. No abstract available.

35.

Impaired information sampling in mild dementia of Alzheimer's type but not in healthy aging.

Zamarian L, Benke T, Brand M, Djamshidian A, Delazer M.

Neuropsychology. 2015 May;29(3):353-67. doi: 10.1037/neu0000157. Epub 2014 Nov 3.

PMID:
25365566
36.

Perceptual decision-making in patients with Parkinson's disease.

Djamshidian A, O'Sullivan SS, Lawrence AD, Foltynie T, Aviles-Olmos I, Magdalinou N, Tomassini A, Warner TT, Lees AJ, Averbeck BB.

J Psychopharmacol. 2014 Dec;28(12):1149-54. doi: 10.1177/0269881114548437. Epub 2014 Sep 18.

PMID:
25237123
37.

Do Parkinson's Disease Patients Have Deficits in Sequential Sampling Tasks?

Djamshidian A, Mulhall J, Tomassini A, Crotty G, Warner TT, Lees A, O'Sullivan SS, Averbeck BB.

Mov Disord Clin Pract. 2014 Jul 31;1(4):325-328. doi: 10.1002/mdc3.12076. eCollection 2014 Dec.

38.

In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Tomassini A, Foltynie T, Limousin P, Aviles-Olmos I, Warner TT, Lees AJ, Averbeck BB.

J Parkinsons Dis. 2014;4(4):579-83. doi: 10.3233/JPD-140388.

39.

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.

Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Kahan J, Ell P, Whitton P, Wyse R, Isaacs T, Lees A, Limousin P, Foltynie T.

J Parkinsons Dis. 2014;4(3):337-44. doi: 10.3233/JPD-140364.

PMID:
24662192
40.

Anxiety and depression in Parkinson's disease.

Djamshidian A, Friedman JH.

Curr Treat Options Neurol. 2014 Apr;16(4):285. doi: 10.1007/s11940-014-0285-6.

PMID:
24532378
41.

Impulsive and compulsive behaviors in Parkinson's disease.

Averbeck BB, O'Sullivan SS, Djamshidian A.

Annu Rev Clin Psychol. 2014;10:553-80. doi: 10.1146/annurev-clinpsy-032813-153705. Epub 2013 Dec 2. Review.

42.

Can stress trigger Parkinson's disease?

Djamshidian A, Lees AJ.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):878-81. doi: 10.1136/jnnp-2013-305911. Epub 2013 Nov 20. Review.

PMID:
24259593
43.

Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, Zrinzo L, Lees AJ, Averbeck BB.

J Parkinsons Dis. 2013;3(2):139-44. doi: 10.3233/JPD-130178.

44.

Exenatide and the treatment of patients with Parkinson's disease.

Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Ell P, Soderlund T, Whitton P, Wyse R, Isaacs T, Lees A, Limousin P, Foltynie T.

J Clin Invest. 2013 Jun;123(6):2730-6.

45.

Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease.

Averbeck BB, Djamshidian A, O'Sullivan SS, Housden CR, Roiser JP, Lees AJ.

Behav Neurosci. 2013 Apr;127(2):245-55. doi: 10.1037/a0032079.

46.

Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.

Djamshidian A, Sanotsky Y, Matviyenko Y, O'Sullivan SS, Sharman S, Selikhova M, Fedoryshyn L, Filts Y, Bearn J, Lees AJ, Averbeck BB.

Addiction. 2013 Apr;108(4):771-9. doi: 10.1111/add.12080. Epub 2013 Feb 11.

47.

Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, Michalczuk R, Aviles-Olmos I, Fedoryshyn L, Doherty KM, Filts Y, Selikhova M, Bowden-Jones H, Joyce E, Lees AJ, Averbeck BB.

Mov Disord. 2012 Aug;27(9):1137-45. doi: 10.1002/mds.25105. Epub 2012 Jul 20.

48.

Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?

Stockner H, Schwingenschuh P, Djamshidian A, Silveira-Moriyama L, Katschnig P, Seppi K, Dickson J, Edwards MJ, Lees AJ, Poewe W, Bhatia KP.

Mov Disord. 2012 Aug;27(9):1182-5. doi: 10.1002/mds.25102. Epub 2012 Jun 28.

49.

Effects of dopamine on sensitivity to social bias in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Lees A, Averbeck BB.

PLoS One. 2012;7(3):e32889. doi: 10.1371/journal.pone.0032889. Epub 2012 Mar 9.

50.

Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.

Djamshidian A, Averbeck BB, Lees AJ, O'Sullivan SS.

J Neurol Sci. 2011 Nov 15;310(1-2):183-8. doi: 10.1016/j.jns.2011.07.031. Epub 2011 Aug 11. Review.

PMID:
21839478

Supplemental Content

Loading ...
Support Center